Literature DB >> 478044

Laboratory investigations in patients with generalized psoriasis under oral retinoid treatment. A multicenter study of computerized data.

C E Orfanos, G Mahrle, G Goerz, R Happle, M Hofbauer, E Landes, A Schimpf.   

Abstract

Numerous laboratory parameters were examined 235 patients with generalized psoriasis treated orally with retinoid and in 35 patients treated topically with anthralin as control. Computer evaluation of the obtained data revealed statistical trends to elevation of the total serum bilirubin level and increasing number of blood monocytes after long-term oral treatment. No other statistically significant changes of the laboratory data were found. Particularly, the liver function tests (transaminases, prothrombin and alkaline phosphatase) showed no significant alterations. Only in a few cases did the retinoid compound have an influence on the GPT and GOT levels. The reasons for this individual sensitivity to the drug remain unknown. No significant alterations were found in the control group treated topically with anthralin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478044     DOI: 10.1159/000250563

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  7 in total

Review 1.  [Retinoids in dermatopharmacology].

Authors:  P M Amann; H F Merk; J M Baron
Journal:  Hautarzt       Date:  2014-02       Impact factor: 0.751

Review 2.  Etretinate therapy in children with severe keratinization defects.

Authors:  H Traupe; R Happle
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

Review 3.  Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases.

Authors:  F G Larsen; F Nielsen-Kudsk; P Jakobsen; K Weismann; K Kragballe
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Hepatocanalicular injury associated with vitamin A derivative etretinate. An idiosyncratic hypersensitivity reaction.

Authors:  M R Khouri; S H Saul; A A Dlugosz; R D Soloway
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

Review 5.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

Review 6.  Adverse reactions to oral retinoids. An update.

Authors:  C M Mills; R Marks
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

7.  Alstonia scholaris R. Br. Significantly Inhibits Retinoid-Induced Skin Irritation In Vitro and In Vivo.

Authors:  Soo-Jin Lee; Sun-A Cho; Su-Sun An; Yong-Joo Na; Nok-Hyun Park; Han-Sung Kim; Chan-Woo Lee; Han-Kon Kim; Eun-Kyung Kim; Young-Pyo Jang; Jin-Woong Kim
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-08       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.